Advertisement
Research Article| Volume 13, ISSUE 2, P159-167, February 1984

Isolation of prostaglandin E2-like material from osteonecrosis induced by steroids and its prevention by kallikrein-inhibitor, aprotinin

An Experimental Study in Rabbits
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Prostaglandin E2 (PGE2)-like activity was measured in osteonecrotic femoral heads caused by high doses of methyl prednisolone acetate in rabbits. Serum levels of cholesterol, total lipids, free fatty acids, alkaline phosphatase, SGOT and lipase were also determined. There were increases in local tissue PGE2-like activity, serum cholesterol, total lipid and free fatty acid levels in rabbits with steroid-induced osteonecrosis as compared to the controls. The rabbits given aprotinin together with the steroid showed significant decreases in serum cholesterol and lipid levels coupled with a marked increase in the local PGE2-like activity. Aprotinin prevented osteonecros is induced by steroids. The results are discussed in the light of the relevant literature.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abeles M.
        • Urman J.D.
        • Rothgfield N.F.
        Aseptic necrosisof bone in systemic lupus erythematosus.Relationship to corticosteroid therapy.
        Arch. Intern. Med. 1978; 138: 750
        • Cosgriff S.W.
        Thromboembolic complications associated with acth and cortisone therapy.
        J.A.M.A. 1951; 147: 924
        • Fisher D.E.
        • Bickel W.H.
        Corticosteroid-induced avascular necrosis.
        J. Bone Joint Surg. 1971; 53-A: 859
        • Ibels L.S.
        • Alfrey A.C.
        Aseptic necrosis of bone following renal transplantation : Experience in 194 transplant recipients and review of the literature.
        Medicine. 1977; 57: 985
        • Levine E.
        • Erken E.R.
        Osteonecrosis following renal transplantation.
        Am. J. Roentgenol. 1977; 128: 985
        • Habermann E.T.
        • Cristofaro R.L.
        Avascular necrosis of Bone as a complication of renal transplantation.
        in: 8th ed. Seminars in Arthritis Rheum. 6. 1976: 189 (2)
        • Cruess R.L.
        • Ross D.
        • Crawshaw E.
        The etiology of steroid-induced avascular necrosis of bone.
        Clin. Orthop. 1975; 113: 178
        • Fisher D.E.
        • Bickel W.H.
        Histologic demonstration of fat emboli in aseptic necrosis asscociated with hypercortisonism.
        in: 8th ed. Mayo Clin. Proc.44. 1969: 252
        • Wang G.J.
        • Moga D.B.
        Cortisone induced bone changes and its response to lipid clearing agents.
        Clin. Orthop. 1978; 130: 81
        • Davidson J.K.
        Aseptic necrosis of bone.
        in: Elsevier Pub. Co, New York1976: 59
        • Fisher D.E.
        • Bickel W.H.
        Corticosteroid-induced aseptic necrosis. II. Experimental study.
        Clin. Orthop. 1972; 84: 200
        • Gold E.W.
        • Fox O.D.
        Corticosteroid-induced avascular necrosis : An experimental study in rabbits.
        Clin. Orthop. 1978; 135: 272
        • Wang G.J.
        • Sweet D.E.
        Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone, —Treated Rabbits.
        J. Bone Joint Surg. 1977; 59-A: 729
        • Beliel O.M.
        • Singer F.R.
        • Coburn J.W.
        Prostaglandins; Effect on plasma calcium concentration.
        Prostaglandins. 1973; 3: 237
        • Raisz L.G.
        • Beynem SR, Kooleman
        Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture.
        Prostaglandins. 1974; 8: 377
        • Vanderwiel C.J.
        • Talmage R.V.
        Comparison of the effects of prostaglandin E2 and parathyroid hormone on plasma calcium concentration and osteoclast function.
        Endocrinology. 1979; 105: 588
        • Yoneda T.
        • Mundy G.R.
        Prostaglandins are necessary for osteoclastactivating factor production by activated peripheral blood leukocytes.
        J. Exp. Mad. 1979; 149: 279
        • Erdös E.
        The kinins.
        Biochem. Pharmacol. 1976; 25: 1563
        • Leffler H.H.
        • McDougald H.
        Estimation of cholesterol in serum.
        Am. J. Clin. Pathol. 1963; 39: 311
        • Bauer J.D.
        • Ackerman P.G.
        • Toro G.
        Clinical laboratory methods.
        in: 8th ed. Mosby Co, St. Louis1974: 454
        • Hans-ulrich Bergmer
        Methods of Enzymatic Analysis.
        in: Academic Press, New York1965: 454-854
        • Fister H.J.
        Manual of standardized procedures for spectrophotometric chemistry. Standard Scientific Supply Corporation, New York1950: 251
        • Ansttall H.B.
        • Trujillo J.M.
        Determination of free fatty acids in plasma by a calorimetric procedure, An appraisal of the method and comparison with other techniques.
        Clin. Chemist. 1965; 11: 741
        • Gilmore N.
        • Vane J.R.
        • Wyllie S.H.
        Prostaglandin release by the spleen.
        Nature (New Biol.). 1968; 218: 1135
        • Vane J.R.
        A sensitive method for assay of 5-hydroxytryptamine.
        Brit. J. Plarmacol. 1957; 12: 344
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        in: McMillan Publishing Co., Inc, New York, Toronto, London1975: 640
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        in: McMillan Publishing Co., Inc, New York, Toronto, London1975: 1480
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        in: McMillan Publishing Co., Inc, New York, Toronto, London1975: 1481
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        in: McMillan Publishing Co., Inc, New York, Toronto, London1975: 1482
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        in: McMillan Publishing Co., Inc, New York, Toronto, London1975: 1484
      1. Türker RK : Personal Communication.

        • Flower R.
        • Gryglewski R.
        • Herbacynska-Cedro K.
        • Vane J.R.
        Effect of antiinflammatory drugs on prostaglandin biosynthesis.
        Nature (New Biol.). 1972; 238: 104
        • Rome I.H.
        • Lands W.E.M.
        Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-imflammatory drugs.
        in: Proc. Natl. Acad. Sci. U.S.A.72. 1975: 4863
        • Grodzinska L.
        • Dembinska Kiec A.
        Hydrocortisone and the release of prostaglandins from spleen.
        Prostaglandins. 1977; 13: 125
        • Gryglewski R.J.
        • Panczenko B.
        • Korbut R.
        • Gordzinska L.
        • Ocetkiewicz A.
        Corticosteroids inhibit prostaglandin lungs of sensitized guinea pig.
        Prostaglandins. 1975; 10: 343
        • Newcombe D.S.
        • Fahey J.V.
        • Ishikawa Y.
        Hydrocortisone inhibition of the bradykinin activationof human synovial f ibroblasts.
        Prostaglandins. 1977; 13: 235
        • Cruess R.L.
        • Sakai T.
        Effect of cortisone upon synthesis rates of some components of rat bone matrix.
        Clin. Orthop. 1972; 86: 253
        • Vogel R.
        • Zickgraf-Rüdel G.
        Evaluation of the role of kinins in Experimental, Pathological and Clinical Conditions, the Therapeutic use of Kallikre in Inhibitor.
        in: Handbook of Experimental Pharmacology. Vol. XXV. Springer-Verlag, Berlin, Heidelberg, New York1970: 550-578
        • Donatelli L.
        • Marino A.
        • Haberland G.L.
        • Matis P.
        Proteas and antiproteases in cardioangiology.
        F.K. Schattauer Verlag, Stuttgart, New York1970
        • Haberland G.L.
        • Cantin M.
        • Schnells G.
        • Selye H.
        New aspects of Trasylol Therapy.
        F.K. Schattauer Verlag, Stuttgart, New York1975
        • Belardo W.T.
        Formation of bradykinin in anaphylactic and peptone shock.
        Am. J. Physiol. 1950; 163: 283
        • Özge-Anwar A.H.
        • Movat H.Z.
        • Scott J.G.
        The kinin system of human plasma.
        Thromb. Diathes. Haemorrh. (Stutg.). 1972; 27: 141